Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Value of Asprosin As a Biomarker in Breast Cancer

NCT06592560 is registered in ClinicalTrials.gov with Marina Hanna Thabet Ghobrial as lead sponsor.

NCT NCT06592560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06592560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Value of Asprosin As a Biomarker in Breast Cancer
Lead sponsor
Marina Hanna Thabet Ghobrial
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2024
Completion date
October 31, 2025
Enrollment
84 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer